Sunshine Biopharma Inc. (SBFMW) Total liabilities 2017–2025
Sunshine Biopharma Inc. (SBFMW) total liabilities at each fiscal year-end, per SEC filings.
$7.0MFY2025 · since FY2017: $830,848 → $7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.0M | -0.3% |
| FY2024 | $7.1M | +15.0% |
| FY2023 | $6.1M | -19.4% |
| FY2022 | $7.6M | +282.5% |
| FY2021 | $2.0M | -0.5% |
| FY2020 | $2.0M | +140.0% |
| FY2019 | $833,527 | -30.7% |
| FY2018 | $1.2M | +44.7% |
| FY2017 | $830,848 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Shareholders’ equitySBFMW overview →